Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site footer’s revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check23 days agoChange DetectedA notice about NIH website terminology changes appears above the study record, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference0.5%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.7.0 was added to the study history, and the previous v3.6.6 entry was removed. This updates the page's revision history to reflect the latest version of the record.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.6.6 was added to the page history and Revision: v3.6.5 was removed. This reflects an update to the page's revision metadata within the record history.SummaryDifference0.1%

Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.